FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3902611000001108: Terazosin 2mg tablets 21 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21739301000001119 Terazosin 2mg tablets 21 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21739401000001110 Terazosin 2mg tablets 21 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Terazosin 2mg tablets 21 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Terazosin 2mg tablets 21 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Terazosin 2mg tablets 21 tablet Is pack of Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Terazosin 2mg tablets 21 tablet Has active ingredient Terazosin hydrochloride false Inferred relationship Existential restriction modifier
Terazosin 2mg tablets 21 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Terazosin 2mg tablets 21 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Terazosin 2mg tablets 21 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Terazosin 2mg tablets 21 tablet Has VMP Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Terazosin 2mg tablets 21 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Terazosin true Inferred relationship Existential restriction modifier
Terazosin 2mg tablets 21 tablet Has specific active ingredient Terazosin hydrochloride true Inferred relationship Existential restriction modifier
Terazosin 2mg tablets 21 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Terazosin 2mg tablets 21 tablet Has basis of strength substance Terazosin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Hytrin 2mg tablets (Abbott Laboratories Ltd) 21 tablet Is a True Terazosin 2mg tablets 21 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start